| Style | Citing Format |
|---|---|
| MLA | Rostami S, et al.. "Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2." Advanced Biomedical Research, vol. 12, no. 1, 2023, pp. -. |
| APA | Rostami S, Ahangarzadeh S, Zamanimoghaddam A, Nokhodian Z, Modaresifar H, Roustaei A, Shoaei P, Rowzati M, Tahvilian Z, Nazari A, Kassaeian N, Haghjoojavanmard S, Ataei B (2023). Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2. Advanced Biomedical Research, 12(1), -. |
| Chicago | Rostami S, Ahangarzadeh S, Zamanimoghaddam A, Nokhodian Z, Modaresifar H, Roustaei A, Shoaei P, et al.. "Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2." Advanced Biomedical Research 12, no. 1 (2023): -. |
| Harvard | Rostami S et al. (2023) 'Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2', Advanced Biomedical Research, 12(1), pp. -. |
| Vancouver | Rostami S, Ahangarzadeh S, Zamanimoghaddam A, Nokhodian Z, Modaresifar H, Roustaei A, et al.. Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2. Advanced Biomedical Research. 2023;12(1):-. |
| BibTex | @article{ author = {Rostami S and Ahangarzadeh S and Zamanimoghaddam A and Nokhodian Z and Modaresifar H and Roustaei A and Shoaei P and Rowzati M and Tahvilian Z and Nazari A and Kassaeian N and Haghjoojavanmard S and Ataei B}, title = {Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2}, journal = {Advanced Biomedical Research}, volume = {12}, number = {1}, pages = {-}, year = {2023} } |
| RIS | TY - JOUR AU - Rostami S AU - Ahangarzadeh S AU - Zamanimoghaddam A AU - Nokhodian Z AU - Modaresifar H AU - Roustaei A AU - Shoaei P AU - Rowzati M AU - Tahvilian Z AU - Nazari A AU - Kassaeian N AU - Haghjoojavanmard S AU - Ataei B TI - Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2 JO - Advanced Biomedical Research VL - 12 IS - 1 SP - EP - PY - 2023 ER - |